Medical - Healthcare Plans
Compare Stocks
4 / 10Stock Comparison
CVS vs AMZN vs WMT vs AMGN
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Retail
Specialty Retail
Drug Manufacturers - General
CVS vs AMZN vs WMT vs AMGN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Healthcare Plans | Specialty Retail | Specialty Retail | Drug Manufacturers - General |
| Market Cap | $111.32B | $2.96T | $1.04T | $178.70B |
| Revenue (TTM) | $407.90B | $742.78B | $703.06B | $37.24B |
| Net Income (TTM) | $2.93B | $90.80B | $22.91B | $7.80B |
| Gross Margin | 13.9% | 50.6% | 24.9% | 71.5% |
| Operating Margin | 1.5% | 11.5% | 4.1% | 31.6% |
| Forward P/E | 12.1x | 35.3x | 44.7x | 14.8x |
| Total Debt | $93.59B | $152.99B | $67.09B | $54.60B |
| Cash & Equiv. | $8.51B | $86.81B | $10.73B | $9.13B |
CVS vs AMZN vs WMT vs AMGN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CVS Health Corporat… (CVS) | 100 | 132.5 | +32.5% |
| Amazon.com, Inc. (AMZN) | 100 | 225.1 | +125.1% |
| Walmart Inc. (WMT) | 100 | 314.6 | +214.6% |
| Amgen Inc. (AMGN) | 100 | 144.1 | +44.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CVS vs AMZN vs WMT vs AMGN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CVS carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.05, yield 3.1%
- Lower volatility, beta 0.05, current ratio 0.84x
- Beta 0.05, yield 3.1%, current ratio 0.84x
- Lower P/E (12.1x vs 14.8x)
AMZN is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 12.4%, EPS growth 29.7%, 3Y rev CAGR 11.7%
- 7.2% 10Y total return vs WMT's 5.0%
- PEG 1.26 vs AMGN's 5.04
- 12.4% revenue growth vs WMT's 4.7%
WMT lags the leaders in this set but could rank higher in a more targeted comparison.
AMGN is the clearest fit if your priority is quality.
- 20.9% margin vs CVS's 0.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.4% revenue growth vs WMT's 4.7% | |
| Value | Lower P/E (12.1x vs 14.8x) | |
| Quality / Margins | 20.9% margin vs CVS's 0.7% | |
| Stability / Safety | Beta 0.05 vs AMZN's 1.51 | |
| Dividends | 3.1% yield, vs WMT's 0.7%, (1 stock pays no dividend) | |
| Momentum (1Y) | +48.6% vs AMGN's +26.0% | |
| Efficiency (ROA) | 11.5% ROA vs CVS's 1.1%, ROIC 14.7% vs 5.0% |
CVS vs AMZN vs WMT vs AMGN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CVS vs AMZN vs WMT vs AMGN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMGN leads in 2 of 6 categories
CVS leads 1 • AMZN leads 0 • WMT leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AMGN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 19.9x AMGN's $37.2B. AMGN is the more profitable business, keeping 20.9% of every revenue dollar as net income compared to CVS's 0.7%. On growth, AMZN holds the edge at +16.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $407.9B | $742.8B | $703.1B | $37.2B |
| EBITDAEarnings before interest/tax | $9.4B | $155.9B | $42.8B | $15.6B |
| Net IncomeAfter-tax profit | $2.9B | $90.8B | $22.9B | $7.8B |
| Free Cash FlowCash after capex | $7.4B | -$2.5B | $15.3B | $8.6B |
| Gross MarginGross profit ÷ Revenue | +13.9% | +50.6% | +24.9% | +71.5% |
| Operating MarginEBIT ÷ Revenue | +1.5% | +11.5% | +4.1% | +31.6% |
| Net MarginNet income ÷ Revenue | +0.7% | +12.2% | +3.3% | +20.9% |
| FCF MarginFCF ÷ Revenue | +1.8% | -0.3% | +2.2% | +23.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.2% | +16.6% | +5.8% | +5.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +63.1% | +74.8% | +35.1% | +4.4% |
Valuation Metrics
CVS leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 23.3x trailing earnings, AMGN trades at a 63% valuation discount to CVS's 62.5x P/E. Adjusting for growth (PEG ratio), AMZN offers better value at 1.37x vs AMGN's 7.91x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $111.3B | $2.96T | $1.04T | $178.7B |
| Enterprise ValueMkt cap + debt − cash | $196.4B | $3.02T | $1.09T | $224.2B |
| Trailing P/EPrice ÷ TTM EPS | 62.49x | 38.35x | 47.65x | 23.27x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.13x | 35.26x | 44.67x | 14.83x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.37x | 4.33x | 7.91x |
| EV / EBITDAEnterprise value multiple | 13.10x | 20.74x | 24.83x | 14.15x |
| Price / SalesMarket cap ÷ Revenue | 0.28x | 4.12x | 1.45x | 4.86x |
| Price / BookPrice ÷ Book value/share | 1.46x | 7.24x | 10.44x | 20.73x |
| Price / FCFMarket cap ÷ FCF | 14.26x | 384.26x | 24.94x | 22.06x |
Profitability & Efficiency
AMGN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
AMGN delivers a 89.4% return on equity — every $100 of shareholder capital generates $89 in annual profit, vs $4 for CVS. AMZN carries lower financial leverage with a 0.37x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMGN's 6.31x. On the Piotroski fundamental quality scale (0–9), AMGN scores 7/9 vs CVS's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.9% | +23.3% | +22.3% | +89.4% |
| ROA (TTM)Return on assets | +1.1% | +11.5% | +7.9% | +8.6% |
| ROICReturn on invested capital | +5.0% | +14.7% | +14.7% | +14.8% |
| ROCEReturn on capital employed | +6.1% | +15.3% | +17.5% | +16.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 6 | 7 |
| Debt / EquityFinancial leverage | 1.24x | 0.37x | 0.67x | 6.31x |
| Net DebtTotal debt minus cash | $85.1B | $66.2B | $56.4B | $45.5B |
| Cash & Equiv.Liquid assets | $8.5B | $86.8B | $10.7B | $9.1B |
| Total DebtShort + long-term debt | $93.6B | $153.0B | $67.1B | $54.6B |
| Interest CoverageEBIT ÷ Interest expense | 4.19x | 39.96x | 11.85x | 5.02x |
Total Returns (Dividends Reinvested)
Evenly matched — AMZN and WMT each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WMT five years ago would be worth $28,531 today (with dividends reinvested), compared to $11,843 for CVS. Over the past 12 months, AMZN leads with a +48.6% total return vs AMGN's +26.0%. The 3-year compound annual growth rate (CAGR) favors WMT at 37.5% vs CVS's 10.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +10.1% | +21.4% | +15.6% | +1.8% |
| 1-Year ReturnPast 12 months | +35.2% | +48.6% | +33.0% | +26.0% |
| 3-Year ReturnCumulative with dividends | +35.9% | +159.8% | +160.2% | +52.8% |
| 5-Year ReturnCumulative with dividends | +18.4% | +66.3% | +185.3% | +48.7% |
| 10-Year ReturnCumulative with dividends | +3.9% | +715.9% | +505.0% | +161.5% |
| CAGR (3Y)Annualised 3-year return | +10.8% | +37.5% | +37.5% | +15.2% |
Risk & Volatility
Evenly matched — CVS and AMZN each lead in 1 of 2 comparable metrics.
Risk & Volatility
CVS is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than AMZN's 1.51 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 98.7% from its 52-week high vs AMGN's 84.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.05x | 1.51x | 0.12x | 0.60x |
| 52-Week HighHighest price in past year | $88.63 | $278.56 | $134.69 | $391.29 |
| 52-Week LowLowest price in past year | $58.35 | $183.85 | $91.89 | $261.43 |
| % of 52W HighCurrent price vs 52-week peak | +98.0% | +98.7% | +96.6% | +84.6% |
| RSI (14)Momentum oscillator 0–100 | 57.1 | 80.5 | 58.1 | 37.9 |
| Avg Volume (50D)Average daily shares traded | 7.4M | 45.6M | 17.2M | 2.5M |
Analyst Outlook
Evenly matched — CVS and WMT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CVS as "Buy", AMZN as "Buy", WMT as "Buy", AMGN as "Buy". Consensus price targets imply 11.6% upside for AMZN (target: $307) vs 5.4% for WMT (target: $137). For income investors, CVS offers the higher dividend yield at 3.08% vs WMT's 0.72%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $95.20 | $306.77 | $137.04 | $350.76 |
| # AnalystsCovering analysts | 41 | 94 | 64 | 38 |
| Dividend YieldAnnual dividend ÷ price | +3.1% | — | +0.7% | +2.9% |
| Dividend StreakConsecutive years of raises | 0 | — | 37 | 15 |
| Dividend / ShareAnnual DPS | $2.67 | — | $0.94 | $9.45 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.8% | 0.0% |
AMGN leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CVS leads in 1 (Valuation Metrics). 3 tied.
CVS vs AMZN vs WMT vs AMGN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CVS or AMZN or WMT or AMGN a better buy right now?
For growth investors, Amazon.
com, Inc. (AMZN) is the stronger pick with 12. 4% revenue growth year-over-year, versus 4. 7% for Walmart Inc. (WMT). Amgen Inc. (AMGN) offers the better valuation at 23. 3x trailing P/E (14. 8x forward), making it the more compelling value choice. Analysts rate CVS Health Corporation (CVS) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CVS or AMZN or WMT or AMGN?
On trailing P/E, Amgen Inc.
(AMGN) is the cheapest at 23. 3x versus CVS Health Corporation at 62. 5x. On forward P/E, CVS Health Corporation is actually cheaper at 12. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Amazon. com, Inc. wins at 1. 26x versus Amgen Inc. 's 5. 04x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — CVS or AMZN or WMT or AMGN?
Over the past 5 years, Walmart Inc.
(WMT) delivered a total return of +185. 3%, compared to +18. 4% for CVS Health Corporation (CVS). Over 10 years, the gap is even starker: AMZN returned +715. 9% versus CVS's +3. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CVS or AMZN or WMT or AMGN?
By beta (market sensitivity over 5 years), CVS Health Corporation (CVS) is the lower-risk stock at 0.
05β versus Amazon. com, Inc. 's 1. 51β — meaning AMZN is approximately 2886% more volatile than CVS relative to the S&P 500. On balance sheet safety, Amazon. com, Inc. (AMZN) carries a lower debt/equity ratio of 37% versus 6% for Amgen Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CVS or AMZN or WMT or AMGN?
By revenue growth (latest reported year), Amazon.
com, Inc. (AMZN) is pulling ahead at 12. 4% versus 4. 7% for Walmart Inc. (WMT). On earnings-per-share growth, the picture is similar: Amgen Inc. grew EPS 88. 2% year-over-year, compared to -62. 0% for CVS Health Corporation. Over a 3-year CAGR, AMGN leads at 11. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CVS or AMZN or WMT or AMGN?
Amgen Inc.
(AMGN) is the more profitable company, earning 21. 0% net margin versus 0. 4% for CVS Health Corporation — meaning it keeps 21. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMGN leads at 29. 1% versus 2. 6% for CVS. At the gross margin level — before operating expenses — AMGN leads at 70. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CVS or AMZN or WMT or AMGN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Amazon. com, Inc. (AMZN) is the more undervalued stock at a PEG of 1. 26x versus Amgen Inc. 's 5. 04x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, CVS Health Corporation (CVS) trades at 12. 1x forward P/E versus 44. 7x for Walmart Inc. — 32. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMZN: 11. 6% to $306. 77.
08Which pays a better dividend — CVS or AMZN or WMT or AMGN?
In this comparison, CVS (3.
1% yield), AMGN (2. 9% yield), WMT (0. 7% yield) pay a dividend. AMZN does not pay a meaningful dividend and should not be held primarily for income.
09Is CVS or AMZN or WMT or AMGN better for a retirement portfolio?
For long-horizon retirement investors, Walmart Inc.
(WMT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 12), 0. 7% yield, +505. 0% 10Y return). Amazon. com, Inc. (AMZN) carries a higher beta of 1. 51 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (WMT: +505. 0%, AMZN: +715. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CVS and AMZN and WMT and AMGN?
These companies operate in different sectors (CVS (Healthcare) and AMZN (Consumer Cyclical) and WMT (Consumer Defensive) and AMGN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CVS is a mid-cap income-oriented stock; AMZN is a mega-cap quality compounder stock; WMT is a mega-cap quality compounder stock; AMGN is a mid-cap quality compounder stock. CVS, WMT, AMGN pay a dividend while AMZN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.